Ophthalmologic features of Parkinson's disease

Neurology

Volumn 62, Issue 2, 2004, Pages 177-180

  Biousse, V ^a,d   Skibell, B C ^a   Watts, R L ^c   Loupe, D N ^a   Drews Botsch, C ^b   Newman, N J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c The University of Alabama at Birmingham   (United States)

^d EMORY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BINOCULAR CONVERGENCE; BLEPHARITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRY EYE; EYE DISEASE; EYELID REFLEX; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; VISUAL HALLUCINATION;

EID: 0842282474     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000103444.45882.D8     Document Type: Review

References (43)

1. Hutton JT, Morris JL. Vision in Parkinson's disease. Adv Neurol 2001;86:279-288.
2. Zesiewicz TA, Cimino CR, Malek AR, et al. Driving safety in Parkinson's disease. Neurology 2002;59:1787-1788.
3. Hunt LA, Sadun AS, Bassi CJ. Review of the visual system in Parkinson's disease. Optom Vis Sci 1995;72:92-99.
4. Bodis-Wollner I, Tagliati M. The visual system in Parkinson's disease. Adv Neurol 1993;60:390-394.
5. Rodnitzky RL. Visual dysfunction in Parkinson's disease. Clin Neurosci 1998;5:102-106.
6. Antal A, Bandini F, Keri S, Bodis-Wollner I. Visuo-cognitive dysfunctions in Parkinson's disease. Clin Neurosci 1998;5:147-152.
7. Muller T, Woitalla D, Peters S, Kohla K, Przuntek H. Progress of visual dysfunction in Parkinson's disease. Acta Neurol Scand 2002;105:256-260.
8. Levin BE, Llabre MM, Reisman S, et al. Visuospatial impairment in Parkinson's disease. Neurology 1991;41:365-369.
9. Price MJ, Feldman RG, Adelberg D, Kayne H. Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 1992;42:887-890.
10. Diederich NJ, Raman R, Leurgans S, Goetz CG. Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch Neurol 2002;59:1249-1252.
11. Bodis-Wolner Y. Visualizing the next step in Parkinson disease. Arch Neurol 2002;59:1233-1234.
12. Haug BA, Trenkwalder C, Arden GB, Oertel WH, Paulus W. Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease. Mov Disord 1994;9:563-570.
13. Pieri V, Diederich NJ, Raman R, Goetz CG. Decreased color discrimination and contrast sensitivity in Parkinson's disease. J Neurol Sci 2000;172:7-11.
14. Wink B, Harris J. A model of the parkinsonian visual system: support for the dark adaptation hypothesis. Vision Res 2000;40:1937-1946.
15. Ikeda H, Head GM, Ellis CJ. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study. Vision Res 1994;34:2629-2639.
16. Waterson JA, Barnes GR, Grealy MA, Collins S. Abnormalities of smooth eye and head movement control in Parkinson's disease. Ann Neurol 1996;39:749-760.
17. Leigh RJ, Riley DE. Eye movements in parkinsonism: it's saccadic speed that counts. Neurology 2000;54:1018-1019.
18. MacAskill MR, Anderson TJ, Jones RD. Adaptative modification of saccade amplitude in Parkinson's disease. Brain 2002;125:1570-1582.
19. Vidailhet M, Rivaud-Pechoux S, Gouider-Khouda N, et al. Saccades and antisaccades in parkinsonian syndromes. Adv Neurol 1999;80:377-382.
20. Rottach KG, Riley DE, DiScenna AO, Zivotofsky AZ, Leigh RJ. Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes. Ann Neurol 1996;39:368-377.
21. Bolger C, Bojanic S, Sheahan NF, Coakley D, Malone JF. Ocular microtremor in patients with idiopathic Parkinson's syndrome. J Neurol Neurosurg Psychiatry 1999;66:528-531.
22. Shaunak S, O'Sullivan E, Blunt S, et al. Remembered saccades with variable delay in Parkinson's disease. Mov Disord 1999;14:80-86.
23. Rivaud-Pechoux S, Vermersch AI, Gaymard B, et al. Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry 2000;68:381-384.
24. Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa. Mov Disord 1996;11:214-216.
25. Bleckher T, Siemers E, Abel LA, Yee RD. Eye movements in Parkinson's disease: before and after pallidotomy. Invest Ophthalmol Vis Sci 2000;41:2177-2183.
26. Averbuch-Heller L, Stahl JS, Hlavin ML, Leigh RJ. Square-wave jerks induced by pallidotomy in parkinsonian patients. Neurology 1999;52:185-188.
27. Stern MB. The clinical diagnosis of Parkinson's disease and parkinsonian syndromes: diagnosis and assessment. In: Stern MB, Hurtig HI, eds. The comprehensive management of Parkinson's disease. New York: PMA Publishing, 1987:3-50.
28. Leibowitz HM, Waring GO, eds. Corneal disorders, clinical diagnosis and management. 2nd ed. Philadelphia: Saunders, 1998.
29. Repka MX, Claro MC, Loupe DN, Reich SG. Ocular motility in Parkinson's disease. J Pediatr Ophthalmol Strabis 1996;22:144-147.
30. Shore JW, Leone CR, O'connor PS, et al. Botulinum toxin for the treatment of essential blepharospasm. Ophthalmic Surg 1986;17:747-753.
31. Lepore FL, Duvoisin RC. "Apraxia" of lid opening: an involuntary levator inhibition. Neurology 1985;35:423-427.
32. Moss SE, Klein R, Klein BEK. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264-1268.
33. Huang F, Tseng S, Shih M, Kuanfu F. Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes. Ophthalmology 2002;109:1934-1940.
34. Karson CN, LeWitt PA, Calne DB, Wyatt RJ. Blink rates in parkinsonism. Ann Neurol 1982;12:580-583.
35. Kaneko K, Sakamoto K. Spontaneous blinks of Parkinson's disease patients evaluated by EMG and EOG. Electromyogr Clin Neurophysiol 2001;41:87-95.
36. Taylor JR, Elsworth JD, Lawrence MS, et al. Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys. Exp Neurol 1999;158:214-220.
37. Fénelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors. Brain 2000;23:733-745.
38. Barnes J, David AS. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 2001;70:727-733.
39. Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:734-738.
40. Daum KM. Characteristics of convergence insufficiency. J Am Optom Assoc 1988;65:426-438.
41. Brinkley JR, Walonker F. Convergence amplitude insufficiency. Ann Ophthalmol 1983;15:826-831.
42. Cooper J, Duckman R. Convergence insufficiency: incidence, diagnosis, and treatment. J Am Optom Assoc 1978;49:673-680.
43. Biousse V, Newman NJ, Carroll C, et al. Visual fields in patients with posterior Gpi pallidotomy. Neurology 1998;50:258-265.